BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 12127150)

  • 1. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.
    McCormack AL; Thiruchelvam M; Manning-Bog AB; Thiffault C; Langston JW; Cory-Slechta DA; Di Monte DA
    Neurobiol Dis; 2002 Jul; 10(2):119-27. PubMed ID: 12127150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
    Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease.
    Ossowska K; Smiałowska M; Kuter K; Wierońska J; Zieba B; Wardas J; Nowak P; Dabrowska J; Bortel A; Biedka I; Schulze G; Rommelspacher H
    Neuroscience; 2006 Sep; 141(4):2155-65. PubMed ID: 16797138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration.
    Purisai MG; McCormack AL; Cumine S; Li J; Isla MZ; Di Monte DA
    Neurobiol Dis; 2007 Feb; 25(2):392-400. PubMed ID: 17166727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
    Thiruchelvam M; Richfield EK; Baggs RB; Tank AW; Cory-Slechta DA
    J Neurosci; 2000 Dec; 20(24):9207-14. PubMed ID: 11124998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration.
    McCormack AL; Atienza JG; Langston JW; Di Monte DA
    Neuroscience; 2006 Aug; 141(2):929-937. PubMed ID: 16677770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
    Rojo AI; Cavada C; de Sagarra MR; Cuadrado A
    Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice.
    Minnema DJ; Travis KZ; Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck MJ; Mathews JM; Tisdel MO; Cook AR; Botham PA; Smith LL
    Regul Toxicol Pharmacol; 2014 Mar; 68(2):250-8. PubMed ID: 24389362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats.
    Cicchetti F; Lapointe N; Roberge-Tremblay A; Saint-Pierre M; Jimenez L; Ficke BW; Gross RE
    Neurobiol Dis; 2005 Nov; 20(2):360-71. PubMed ID: 16242641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice.
    Li X; Matsumoto K; Murakami Y; Tezuka Y; Wu Y; Kadota S
    Pharmacol Biochem Behav; 2005 Oct; 82(2):345-52. PubMed ID: 16214209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat.
    Hutson CB; Lazo CR; Mortazavi F; Giza CC; Hovda D; Chesselet MF
    J Neurotrauma; 2011 Sep; 28(9):1783-801. PubMed ID: 21644813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse.
    Bezard E; Jaber M; Gonon F; Boireau A; Bloch B; Gross CE
    Eur J Neurosci; 2000 Aug; 12(8):2892-900. PubMed ID: 10971632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype.
    Thiruchelvam M; McCormack A; Richfield EK; Baggs RB; Tank AW; Di Monte DA; Cory-Slechta DA
    Eur J Neurosci; 2003 Aug; 18(3):589-600. PubMed ID: 12911755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice.
    Kang MJ; Gil SJ; Koh HC
    Toxicol Lett; 2009 Jul; 188(2):148-52. PubMed ID: 19446248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of oxidative stress in paraquat-induced dopaminergic cell degeneration.
    McCormack AL; Atienza JG; Johnston LC; Andersen JK; Vu S; Di Monte DA
    J Neurochem; 2005 May; 93(4):1030-7. PubMed ID: 15857406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regional expression patterns of α-synuclein, TNF-α, and IL-1β; and variable status of dopaminergic neurotoxicity in mouse brain after Paraquat treatment.
    Mitra S; Chakrabarti N; Bhattacharyya A
    J Neuroinflammation; 2011 Nov; 8():163. PubMed ID: 22112368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining.
    Ares-Santos S; Granado N; Espadas I; Martinez-Murillo R; Moratalla R
    Neuropsychopharmacology; 2014 Apr; 39(5):1066-80. PubMed ID: 24169803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice.
    Li X; Yin J; Cheng CM; Sun JL; Li Z; Wu YL
    Chin Med J (Engl); 2005 Aug; 118(16):1357-61. PubMed ID: 16157030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?
    Ossowska K; Wardas J; Smiałowska M; Kuter K; Lenda T; Wierońska JM; Zieba B; Nowak P; Dabrowska J; Bortel A; Kwieciński A; Wolfarth S
    Eur J Neurosci; 2005 Sep; 22(6):1294-304. PubMed ID: 16190885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.